Biotage AB BIOT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 162.90
- Day Range
- SEK 160.70–163.60
- 52-Week Range
- SEK 83.05–187.10
- Bid/Ask
- SEK 161.10 / SEK 161.60
- Market Cap
- SEK 12.86 Bil
- Volume/Avg
- 84,575 / 106,057
Key Statistics
- Price/Earnings (Normalized)
- 33.24
- Price/Sales
- 6.50
- Dividend Yield (Trailing)
- 1.00%
- Dividend Yield (Forward)
- 1.00%
- Total Yield
- 0.98%
Company Profile
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 674
- Website
- https://www.biotage.com
Comparables
Valuation
|
Metric
|
BIOT
|
AKYA
|
TECH
|
|---|---|---|---|
Price/Earnings (Normalized) | 33.24 | — | 33.69 |
Price/Book Value | 3.58 | 3.54 | 5.10 |
Price/Sales | 6.50 | 1.78 | 8.98 |
Price/Cash Flow | 32.70 | — | 31.36 |
Price/Earnings
BIOT
AKYA
TECH
Financial Strength
|
Metric
|
BIOT
|
AKYA
|
TECH
|
|---|---|---|---|
Quick Ratio | 1.39 | 2.83 | 2.54 |
Current Ratio | 2.05 | 3.45 | 4.37 |
Interest Coverage | 23.62 | −6.62 | 18.34 |
Quick Ratio
BIOT
AKYA
TECH
Profitability
|
Metric
|
BIOT
|
AKYA
|
TECH
|
|---|---|---|---|
Return on Assets (Normalized) | 5.71% | −30.67% | 11.61% |
Return on Equity (Normalized) | 7.77% | −93.26% | 15.75% |
Return on Invested Capital (Normalized) | 7.15% | −36.71% | 13.09% |
Return on Assets
BIOT
AKYA
TECH
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Cygltbsq | Gxsq | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Clgnzlw | Wywqxqy | $67.6 Bil | |
ALC
| Alcon Inc | Sddwjjc | Msccyj | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Vcsfvnlws | Wdtzw | $29.4 Bil | |
WST
| West Pharmaceutical Services Inc | Wpntcqwwc | Xtvnb | $28.6 Bil | |
RMD
| ResMed Inc | Wxlqnjqkj | Gtcrym | $27.1 Bil | |
BAX
| Baxter International Inc | Rxtxfqpw | Cwcjz | $20.9 Bil | |
COO
| The Cooper Companies Inc | Xhhjpyvs | Wfjhmk | $18.2 Bil | |
HOLX
| Hologic Inc | Jxlctytzw | Bcttrj | $17.9 Bil | |
TFX
| Teleflex Inc | Bnfss | Fwcdy | $9.9 Bil |